XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statement of Changes in Stockholders' Equity (USD $)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit during Development Stage [Member]
Balance at Apr. 14, 2014 $ 0 $ 0 $ 0 $ 0
Balance (in shares) at Apr. 14, 2014   0    
Common shares issued to initial stockholders 25,000 115 24,885 0
Common shares issued to initial stockholders (in shares)   1,150,000    
Sale of 4,600,000 units at $10 per unit in IPO, including over-allotment, net of underwriters' discount and offering expenses 44,168,215 460 44,167,755 0
Sale of 4,600,000 units at $10 per unit in IPO, including over-allotment, net of underwriters' discount and offering expenses (in shares)   4,600,000    
Sale of 198,000 units at $10 per unit in private placement, including over-allotment 1,980,000 20 1,979,980 0
Sale of 198,000 units at $10 per unit in private placement, including over-allotment (in shares)   198,000    
Sale of 600,000 $15 exercise price warrants at $0.5 per warrant in private placement 300,000 0 300,000  
Issuance of underwriter purchase option 100 0 100 0
Common shares subject to possible redemption (40,999,990) (410) (40,999,580)  
Common shares subject to possible redemption (in shares)   (4,099,999)    
Net loss (83,157) 0 0 (83,157)
Balance at Sep. 30, 2014 $ 5,390,168 $ 185 $ 5,473,140 $ (83,157)
Balance (in shares) at Sep. 30, 2014   1,848,001